Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlushCare vs TeleCareSpot

PlushCare
Graded #64

Higher grade

vs+6.799999999999997
TeleCareSpot
Graded #164

Lower grade

The verdict

PlushCare takes it — 74.5/100 to 67.7/100.

PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlushCare +31
74
43
Dose & formulationTeleCareSpot +6
77
83
Clinical oversightTeleCareSpot +1
82
83
Labs & monitoringPlushCare +25
77
52
FulfillmentTeleCareSpot +14
78
92
Contract termsTeleCareSpot +20
41
61
PlushCare · left barTeleCareSpot · right bar

The numbers

MetricPlushCareTeleCareSpot
WeighScore74.5/10067.7/100
GradeCC
Scorecard rank#64#164
Semaglutide$149/mo (starting dose, compounded)$299/mo (all doses, plus a separate fee, compounded)
Tirzepatide$399/mo (starting dose, compounded)$399/mo
CoverageAll 50 states48 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
PlushCare

Graded #64 · C

Strengths

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Where it loses points

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process
TeleCareSpot

Graded #164 · C

Strengths

  • Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
  • Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
  • Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
  • DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
  • Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Not available in Alaska, Mississippi, or New Jersey
  • The compounding pharmacy partner is not named
  • A separate weight-loss consultation fee applies (credited toward your medication package if approved)
  • Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard